# JSPRW (Jasper Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Jasper Therapeutics, Inc. reported $147.4M in total assets and a net loss of $157.5M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/JSPRW
- Markdown: https://convexityos.com/fundamentals/JSPRW.md
- SEC CIK: 0001788028
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001788028&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$180.2M | Operating profit |
| Net Income | FY 2025 | -$157.5M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$146.47 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $135.3M | Total debt: $69K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cost of Revenue | $41.63M | $34.27M | -- | -- | -- | -- |
| Research & Development | $63.10M | $55.82M | $51.78M | $34.63M | $25.42M | $15.88M |
| Total Operating Expenses | $83.88M | $76.24M | $68.86M | $51.20M | $36.83M | $20.68M |
| **Operating Income** | -$83.88M | -$76.24M | -$68.86M | -$51.20M | -$36.83M | -$20.68M |
| **EBITDA** | -$82.83M | -$74.87M | -$67.75M | -$50.22M | -$36.46M | -- |
| Interest Income | $1.74M | $5.06M | $5.20M | $701K | -- | -- |
| Income Before Tax | -- | -- | -- | -- | -- | -$552K |
| Income Tax Expense | -- | $2.0K | $2.0K | -- | -- | $38K |
| **Net Income** | -$75.80M | -$71.27M | -$64.47M | -$37.69M | -$30.64M | -$31.67M |
| Basic EPS | -$3,379.45 | -$4,183.67 | -$5,287.34 | -$8,837.90 | -$23,014.47 | -$44,232.27 |
| **Diluted EPS** | -$3,379.45 | -$4,183.67 | -$5,287.34 | -$8,837.90 | -$23,014.47 | -$44,232.27 |
| Basic Shares Outstanding | 22.4K | 17.0K | 12.2K | 4.3K | 1.3K | 716 |
| Diluted Shares Outstanding | 22.4K | 17.0K | 12.2K | 4.3K | 1.3K | 716 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $8.00M | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | $4.32M | $3.58M | $3.62M | $6.76M | $9.35M | $15.77M | $9.76M | -- |
| **Gross Profit** | $3.68M | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $8.33M | $5.13M | $5.81M | $11.36M | $14.39M | $21.20M | $16.16M | $19.77M |
| Total Operating Expenses | $152.2M | $9.21M | $10.95M | $15.84M | $19.17M | $27.08M | $21.80M | $25.29M |
| **Operating Income** | -$144.2M | -$9.21M | -$10.95M | -$15.84M | -$19.17M | -$27.08M | -$21.80M | -$25.29M |
| **EBITDA** | -$144.2M | -$9.19M | -$10.93M | -$15.55M | -$18.94M | -$26.82M | -$21.52M | -$25.04M |
| Interest Income | $999K | $82K | $164K | $338K | $342K | $437K | $624K | $938K |
| **Net Income** | -$144.5M | -$2.76M | -$1.17M | -$9.10M | -$18.74M | -$26.72M | -$21.24M | -$24.32M |
| Basic EPS | -$10.19 | -$85.56 | -$34.22 | -- | -$32.08 | -$1,488.67 | -$1,206.33 | -- |
| **Diluted EPS** | -$10.19 | -$85.56 | -$34.22 | -- | -$32.08 | -$1,488.67 | -$1,206.33 | -- |
| Basic Shares Outstanding | 1.1M | 33.5K | 33.5K | -- | 584.1K | 17.9K | 17.6K | -- |
| Diluted Shares Outstanding | 1.1M | 33.5K | 33.5K | -- | 584.1K | 17.9K | 17.6K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $28.69M | $71.64M | $86.89M | $38.25M | $84.70M | $19.84M | $1.21M |
| **Cash & Short-Term Investments** | $28.69M | $71.64M | $86.89M | $38.25M | $84.70M | $19.84M | $1.21M |
| Other Current Assets | $664K | $646K | $295K | $118K | $219K | -- | -- |
| **Total Current Assets** | $34.65M | $75.81M | $88.94M | $41.73M | $87.83M | $20.68M | $1.54M |
| Property, Plant & Equipment, Net | $102K | $1.88M | $2.73M | $3.57M | $3.69M | $693K | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | $100.3M | $100.2M |
| Other Non-Current Assets | $113K | $820K | $1.34M | $759K | $645K | $298K | -- |
| **Total Non-Current Assets** | $1.13M | $4.09M | $5.95M | $6.63M | $5.82M | $2.67M | $100.2M |
| **Total Assets** | $35.78M | $79.90M | $94.89M | $48.36M | $93.65M | $23.36M | $101.7M |
| Accounts Payable | $6.22M | $4.03M | $4.15M | $1.77M | $3.92M | $1.42M | -- |
| Other Current Liabilities | -- | -- | -- | $194K | $585K | $149K | -- |
| **Total Current Liabilities** | $13.20M | $15.24M | $12.37M | $7.07M | $8.02M | $4.01M | $111K |
| Other Non-Current Liabilities | $2.26M | $2.26M | $2.26M | $2.35M | $643K | $853K | -- |
| **Total Non-Current Liabilities** | $18.43M | $2.99M | $4.08M | $5.31M | $16.12M | $10.63M | $3.50M |
| **Total Liabilities** | $31.63M | $18.23M | $16.45M | $12.37M | $24.14M | $14.65M | $3.61M |
| **Total Debt (incl. Leases)** | $1.24M | $1.81M | $2.79M | $1.09M | $760K | $485K | -- |
| Common Stock | $3.0K | $2.0K | $1.0K | $4.0K | $4.0K | $1.0K | -- |
| Retained Earnings | -$316.7M | -$240.9M | -$169.6M | -$105.1M | -$67.45M | -$36.81M | $2.0K |
| **Total Stockholders' Equity** | $4.15M | $61.67M | $78.44M | $35.99M | $69.52M | -$35.13M | -$4.73M |
| Total Equity | $4.15M | $61.67M | $78.44M | $35.99M | $69.52M | -$35.13M | $101.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $135.3M | $7.31M | $14.14M | $28.69M | $50.90M | $39.51M | $48.80M | $71.64M |
| **Cash & Short-Term Investments** | $135.3M | $7.31M | $14.14M | $28.69M | $50.90M | $39.51M | $48.80M | $71.64M |
| Accounts Receivable, Net | $8.00M | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $636K | $255K | $405K | $664K | $863K | $867K | $854K | $646K |
| **Total Current Assets** | $147.3M | $11.57M | $20.29M | $34.65M | $54.56M | $42.97M | $53.17M | $75.81M |
| Property, Plant & Equipment, Net | $57K | $60K | $81K | $102K | $1.10M | $1.33M | $1.60M | $1.88M |
| Other Non-Current Assets | $18K | $43K | $77K | $113K | $150K | $192K | $532K | $820K |
| **Total Non-Current Assets** | $142K | $231K | $892K | $1.13M | $2.90M | $3.50M | $4.42M | $4.09M |
| **Total Assets** | $147.4M | $11.80M | $21.18M | $35.78M | $57.47M | $46.47M | $57.60M | $79.90M |
| Accounts Payable | $3.76M | $2.78M | $2.44M | $6.22M | $9.17M | $8.03M | $3.00M | $4.03M |
| **Total Current Liabilities** | $13.91M | $7.84M | $9.00M | $13.20M | $21.04M | $20.50M | $12.33M | $15.24M |
| Other Non-Current Liabilities | $1.30M | -- | $2.26M | $2.26M | $2.26M | $2.26M | $2.26M | $2.26M |
| **Total Non-Current Liabilities** | $6.98M | $2.54M | $8.79M | $18.43M | $24.86M | $2.46M | $3.02M | $2.99M |
| **Total Liabilities** | $20.89M | $10.39M | $17.78M | $31.63M | $45.90M | $22.96M | $15.35M | $18.23M |
| **Total Debt (incl. Leases)** | $69K | $270K | $757K | $1.24M | $1.70M | $2.15M | $2.59M | $1.81M |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$465.1M | -$320.6M | -$317.8M | -$316.7M | -$307.6M | -$288.8M | -$262.1M | -$240.9M |
| **Total Stockholders' Equity** | -$140.2M | $1.41M | $3.40M | $4.15M | $11.57M | $23.50M | $42.24M | $61.67M |
| Total Equity | -$140.2M | $1.41M | $3.40M | $4.15M | $11.57M | $23.50M | $42.24M | $61.67M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$75.80M | -$71.27M | -$64.47M | $37.70M | $30.60M | -$31.67M |
| Depreciation & Amortization | $1.06M | $1.37M | $1.11M | $975K | $377K | -- |
| Stock-Based Compensation | $6.71M | $6.62M | $5.21M | $4.09M | $1.05M | $1.21M |
| Change in Receivables | -- | -- | -- | -- | $600K | -- |
| Change in Payables | $2.19M | -$122K | $2.38M | -$2.15M | $2.94M | $358K |
| **Operating Cash Flow** | -$77.16M | -$62.60M | -$52.07M | -$45.86M | -$33.68M | -$18.27M |
| **Investing Cash Flow** | $5.0K | -$532K | -$267K | -$576K | -$2.43M | $198K |
| Common Stock Issued | $6.45M | $47.20M | $101.5M | $28K | -- | -- |
| **Financing Cash Flow** | $34.21M | $47.88M | $101.0M | $55K | $101.0M | $11.29M |
| **Net Change in Cash** | -$42.95M | -$15.25M | $48.64M | -$46.38M | $64.86M | -$443K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$144.5M | -$2.76M | -$1.17M | -$9.10M | -$18.74M | -$26.72M | -$21.24M | -$24.32M |
| Depreciation & Amortization | $17K | $21K | $21K | $290K | $229K | $258K | $279K | $245K |
| Stock-Based Compensation | $1.22M | $764K | $423K | $1.66M | $1.42M | $1.82M | $1.81M | $1.97M |
| Change in Payables | -$2.77M | $339K | -$3.78M | -$2.95M | $1.13M | $5.05M | -$1.04M | $957K |
| **Operating Cash Flow** | -$5.50M | -$6.92M | -$14.55M | -$21.87M | -$17.00M | -$15.45M | -$22.84M | -$21.13M |
| **Investing Cash Flow** | -- | -- | -- | $0 | $0 | $1.0K | $4.0K | -$76K |
| Common Stock Issued | -- | -- | $6.50M | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $345K |
| **Net Change in Cash** | $128.0M | -$6.83M | -$14.55M | -$22.21M | $11.39M | -$9.29M | -$22.84M | -$20.86M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -1826.1% | -115.6% | -82.2% | -104.7% | -44.1% | -- |
| Return on Assets (ROA) | -211.9% | -89.2% | -67.9% | -77.9% | -32.7% | -135.6% |
| Current Ratio | 2.62x | 4.98x | 7.19x | 5.91x | 10.95x | 5.16x |
| Quick Ratio | 2.17x | 4.70x | 7.02x | 5.41x | 10.56x | 4.94x |
| Debt to Equity | 0.30x | 0.03x | 0.04x | 0.03x | 0.01x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -2248.5% | -1639.2% | -1826.1% | -786.6% | -386.9% | -186.5% | -115.6% |
| Return on Assets (ROA) | -106.8% | -269.2% | -263.1% | -211.9% | -158.4% | -195.7% | -136.8% | -89.2% |
| Current Ratio | 10.59x | 1.47x | 2.26x | 2.62x | 2.59x | 2.10x | 4.31x | 4.98x |
| Quick Ratio | 10.30x | 0.93x | 1.57x | 2.17x | 2.42x | 1.93x | 3.96x | 4.70x |
| Debt to Equity | -- | 0.19x | 0.22x | 0.30x | 0.15x | 0.09x | 0.06x | 0.03x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
